| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |